A citation-based method for searching scientific literature

Apostolia M Tsimberidou, Elena Fountzilas, Leonidas Bleris, Razelle Kurzrock. Semin Cancer Biol 2022
Times Cited: 13







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.
Jordi Rodon, Jean-Charles Soria, Raanan Berger, Wilson H Miller, Eitan Rubin, Aleksandra Kugel, Apostolia Tsimberidou, Pierre Saintigny, Aliza Ackerstein, Irene Braña,[...]. Nat Med 2019
217
30

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, Maria Schwaederle, Michael E Hahn, Casey B Williams, Pradip De, Amy Krie, David E Piccioni, Vincent A Miller,[...]. Nat Med 2019
267
23

Review of precision cancer medicine: Evolution of the treatment paradigm.
Apostolia M Tsimberidou, Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock. Cancer Treat Rev 2020
113
23

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
O Trédan, Q Wang, D Pissaloux, P Cassier, A de la Fouchardière, J Fayette, F Desseigne, I Ray-Coquard, C de la Fouchardière, D Frappaz,[...]. Ann Oncol 2019
83
23

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.
Christophe Massard, Stefan Michiels, Charles Ferté, Marie-Cécile Le Deley, Ludovic Lacroix, Antoine Hollebecque, Loic Verlingue, Ecaterina Ileana, Silvia Rosellini, Samy Ammari,[...]. Cancer Discov 2017
368
23

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.
Daniel D Von Hoff, Joseph J Stephenson, Peter Rosen, David M Loesch, Mitesh J Borad, Stephen Anthony, Gayle Jameson, Susan Brown, Nina Cantafio, Donald A Richards,[...]. J Clin Oncol 2010
433
15

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data.
Beifang Niu, Kai Ye, Qunyuan Zhang, Charles Lu, Mingchao Xie, Michael D McLellan, Michael C Wendl, Li Ding. Bioinformatics 2014
375
15

Comparative genomic analysis of primary tumors and metastases in breast cancer.
François Bertucci, Pascal Finetti, Arnaud Guille, José Adélaïde, Séverine Garnier, Nadine Carbuccia, Audrey Monneur, Emmanuelle Charafe-Jauffret, Anthony Goncalves, Patrice Viens,[...]. Oncotarget 2016
53
15

Genomic characterization of metastatic breast cancers.
François Bertucci, Charlotte K Y Ng, Anne Patsouris, Nathalie Droin, Salvatore Piscuoglio, Nadine Carbuccia, Jean Charles Soria, Alicia Tran Dien, Yahia Adnani, Maud Kamal,[...]. Nature 2019
305
15

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
V Abkevich, K M Timms, B T Hennessy, J Potter, M S Carey, L A Meyer, K Smith-McCune, R Broaddus, K H Lu, J Chen,[...]. Br J Cancer 2012
404
15

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Tracy L Stockley, Amit M Oza, Hal K Berman, Natasha B Leighl, Jennifer J Knox, Frances A Shepherd, Eric X Chen, Monika K Krzyzanowska, Neesha Dhani, Anthony M Joshua,[...]. Genome Med 2016
153
15

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative.
Apostolia-Maria Tsimberidou, Nancy G Iskander, David S Hong, Jennifer J Wheler, Gerald S Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Rajyalakshmi Luthra,[...]. Clin Cancer Res 2012
378
15

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).
Fabrice André, Thomas Bachelot, Frederic Commo, Mario Campone, Monica Arnedos, Véronique Dieras, Magali Lacroix-Triki, Ludovic Lacroix, Pascale Cohen, David Gentien,[...]. Lancet Oncol 2014
276
15

OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
15

Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses.
Apostolia-Maria Tsimberidou, Sijin Wen, David S Hong, Jennifer J Wheler, Gerald S Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Kenneth Aldape,[...]. Clin Cancer Res 2014
149
15

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience.
Maria Schwaederle, Barbara A Parker, Richard B Schwab, Gregory A Daniels, David E Piccioni, Santosh Kesari, Teresa L Helsten, Lyudmila A Bazhenova, Julio Romero, Paul T Fanta,[...]. Mol Cancer Ther 2016
111
15

The European Society for Medical Oncology (ESMO) Precision Medicine Glossary.
L R Yates, J Seoane, C Le Tourneau, L L Siu, R Marais, S Michiels, J C Soria, P Campbell, N Normanno, A Scarpa,[...]. Ann Oncol 2018
52
15

Integrative clinical genomics of metastatic cancer.
Dan R Robinson, Yi-Mi Wu, Robert J Lonigro, Pankaj Vats, Erin Cobain, Jessica Everett, Xuhong Cao, Erica Rabban, Chandan Kumar-Sinha, Victoria Raymond,[...]. Nature 2017
453
15

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Mark G Kris, Bruce E Johnson, Lynne D Berry, David J Kwiatkowski, A John Iafrate, Ignacio I Wistuba, Marileila Varella-Garcia, Wilbur A Franklin, Samuel L Aronson, Pei-Fang Su,[...]. JAMA 2014
15

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
15

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study.
Apostolia-Maria Tsimberidou, David S Hong, Yang Ye, Carrie Cartwright, Jennifer J Wheler, Gerald S Falchook, Aung Naing, Siqing Fu, Sarina Piha-Paul, Filip Janku,[...]. JCO Precis Oncol 2017
93
15

Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts,[...]. Nature 2013
15


Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Maki Tanioka, Cheng Fan, Joel S Parker, Katherine A Hoadley, Zhiyuan Hu, Yan Li, Terry M Hyslop, Brandelyn N Pitcher, Matthew G Soloway, Patricia A Spears,[...]. Clin Cancer Res 2018
43
15

Atlas of RNA sequencing profiles for normal human tissues.
Maria Suntsova, Nurshat Gaifullin, Daria Allina, Alexey Reshetun, Xinmin Li, Larisa Mendeleeva, Vadim Surin, Anna Sergeeva, Pavel Spirin, Vladimir Prassolov,[...]. Sci Data 2019
43
15

Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data.
Nicolas Borisov, Maria Suntsova, Maxim Sorokin, Andrew Garazha, Olga Kovalchuk, Alexander Aliper, Elena Ilnitskaya, Ksenia Lezhnina, Mikhail Korzinkin, Victor Tkachev,[...]. Cell Cycle 2017
34
15

Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments.
Nicolas Borisov, Maxim Sorokin, Victor Tkachev, Andrew Garazha, Anton Buzdin. BMC Med Genomics 2020
14
15

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles.
Nicolas Borisov, Anna Sergeeva, Maria Suntsova, Mikhail Raevskiy, Nurshat Gaifullin, Larisa Mendeleeva, Alexander Gudkov, Maria Nareiko, Andrew Garazha, Victor Tkachev,[...]. Front Oncol 2021
9
22

Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs.
Anton Buzdin, Maxim Sorokin, Andrew Garazha, Marina Sekacheva, Ella Kim, Nikolay Zhukov, Ye Wang, Xinmin Li, Souvik Kar, Christian Hartmann,[...]. Semin Cancer Biol 2018
57
15

Machine Learning in Oncology: What Should Clinicians Know?
Matthew Nagy, Nathan Radakovich, Aziz Nazha. JCO Clin Cancer Inform 2020
21
15

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
15

Surgery for Cancer: A Trigger for Metastases.
Samer Tohme, Richard L Simmons, Allan Tsung. Cancer Res 2017
249
15

Systemic treatment of renal cell cancer: A comprehensive review.
Amparo Sánchez-Gastaldo, Emmanuelle Kempf, Aránzazu González Del Alba, Ignacio Duran. Cancer Treat Rev 2017
87
15

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders. Genome Biol 2014
15

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.
Jeeyun Lee, Seung Tae Kim, Kyung Kim, Hyuk Lee, Iwanka Kozarewa, Peter G S Mortimer, Justin I Odegaard, Elizabeth A Harrington, Juyoung Lee, Taehyang Lee,[...]. Cancer Discov 2019
87
7

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
7

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Andrea M Marquard, Aron C Eklund, Tejal Joshi, Marcin Krzystanek, Francesco Favero, Zhigang C Wang, Andrea L Richardson, Daniel P Silver, Zoltan Szallasi, Nicolai J Birkbak. Biomark Res 2015
132
7

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
607
7

The BATTLE trial: personalizing therapy for lung cancer.
Edward S Kim, Roy S Herbst, Ignacio I Wistuba, J Jack Lee, George R Blumenschein, Anne Tsao, David J Stewart, Marshall E Hicks, Jeremy Erasmus, Sanjay Gupta,[...]. Cancer Discov 2011
582
7

Molecular profiling of platinum resistant ovarian cancer.
Jozien Helleman, Maurice P H M Jansen, Paul N Span, Iris L van Staveren, Leon F A G Massuger, Marion E Meijer-van Gelder, Fred C G J Sweep, Patricia C Ewing, Maria E L van der Burg, Gerrit Stoter,[...]. Int J Cancer 2006
130
7

Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases.
Jing Sun, Cheng Wang, Yi Zhang, Lingyan Xu, Weijia Fang, Yuping Zhu, Yi Zheng, Xiaofeng Chen, Xiju Xie, Xinhua Hu,[...]. Nat Commun 2019
42
7

Implementation and use of whole exome sequencing for metastatic solid cancer.
Manon Réda, Corentin Richard, Aurelie Bertaut, Julie Niogret, Thomas Collot, Jean David Fumet, Julie Blanc, Caroline Truntzer, Isabelle Desmoulins, Sylvain Ladoire,[...]. EBioMedicine 2020
18
7

Consensus on precision medicine for metastatic cancers: a report from the MAP conference.
C Swanton, J-C Soria, A Bardelli, A Biankin, C Caldas, S Chandarlapaty, L de Koning, C Dive, J Feunteun, S-Y Leung,[...]. Ann Oncol 2016
59
7

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
Maria Schwaederle, Melissa Zhao, J Jack Lee, Alexander M Eggermont, Richard L Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock. J Clin Oncol 2015
272
7

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.
M Diossy, L Reiniger, Z Sztupinszki, M Krzystanek, K M Timms, C Neff, C Solimeno, D Pruss, A C Eklund, E Tóth,[...]. Ann Oncol 2018
39
7

Genome sequencing identifies a basis for everolimus sensitivity.
Gopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, Hikmat Al-Ahmadie, Sasinya N Scott, Manickam Janakiraman, Mono Pirun, Chris Sander, Nicholas D Socci, Irina Ostrovnaya,[...]. Science 2012
521
7

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.
Marguerite Tyran, Nadine Carbuccia, Séverine Garnier, Arnaud Guille, José Adelaïde, Pascal Finetti, Julien Toulzian, Patrice Viens, Agnès Tallet, Anthony Goncalves,[...]. Cancers (Basel) 2019
17
7

Prognostic implications of cancer susceptibility genes: any news?
R J Scott, H H Sobol. Recent Results Cancer Res 1999
5
20

Precision oncology: separating the wheat from the chaff.
Jordi Remon, Rodrigo Dienstmann. ESMO Open 2018
24
7

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, Céline Gavoille, Coraline Dubot, Nicolas Isambert, Mario Campone, Olivier Trédan, Marie-Ange Massiani, Cécile Mauborgne,[...]. Lancet Oncol 2015
650
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.